Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 28Terminated 12Unknown 3Recruiting 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 73Head & Neck 51Genitourinary 51Thoracic 48CNS 42Breast 24Gynecologic 13Sarcoma 12Lymphoid 10Tumor-Agnostic 7Dermatologic 5Plasma cell 3Other solid neoplasm 2Other hematologic neoplasm 2Other 2Myeloid 1

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2

Interventions

Dexamethasone 98daratumumab 57Lenalidomide 53Bortezomib 38pomalidomide 37Cyclophosphamide 37carfilzomib 25Calcium Dobesilate 25fludarabine 22talquetamab 19iberdomide 18isatuximab 17Specimen Handling 17Magnetic Resonance Spectroscopy 17Biopsy 15selinexor 13dexamethasone acetate 12belantamab mafodotin 12Melphalan 12dexamethasone 21-phosphate 11auricularum 10venetoclax 8fludarabine phosphate 7elotuzumab 7X-Rays 6tocilizumab 5Blood Specimen Collection 5ruxolitinib 4ixazomib 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Radiotherapy × Plasma cell × Clear all
NCT05336383 2026-04-15

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03858205 2025-07-11

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

University of Southern California

Phase NA Recruiting
100 enrolled
Plasma cell

Multiple Myeloma

NCT05248633 2024-06-05

Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

Peking Union Medical College Hospital

Phase 2 Recruiting
220 enrolled
Plasma cell

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡